Peginterferon alfa-2b Interactions
There are 204 drugs known to interact with peginterferon alfa-2b, along with 20 disease interactions. Of the total drug interactions, 40 are major, 160 are moderate, and4 are minor.
- View all 204 medications that may interact with peginterferon alfa-2b
- View peginterferon alfa-2b disease interactions (20)
Most frequently checked interactions
View interaction reports for peginterferon alfa-2b and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Adderall (amphetamine / dextroamphetamine)
- Aleve (naproxen)
- Ativan (lorazepam)
- Avelox (moxifloxacin)
- Avodart (dutasteride)
- Benadryl (diphenhydramine)
- Chantix (varenicline)
- Claritin (loratadine)
- Concerta (methylphenidate)
- Diovan (valsartan)
- Effexor XR (venlafaxine)
- Flexeril (cyclobenzaprine)
- Haldol Decanoate (haloperidol)
- Hycodan (homatropine / hydrocodone)
- Imodium (loperamide)
- Incivek (telaprevir)
- Indium In-111 DTPA (indium pentetate in-111)
- Klor-Con (potassium chloride)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Morphine Sulfate ER (morphine)
- MSIR (morphine)
- Naftin (naftifine topical)
- Nasonex (mometasone nasal)
- Neurontin (gabapentin)
- Nexium (esomeprazole)
- Niaspan (niacin)
- Symbicort (budesonide / formoterol)
- Zoloft (sertraline)
Peginterferon alfa-2b disease interactions
There are 20 disease interactions with peginterferon alfa-2b which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
More about peginterferon alfa-2b
- peginterferon alfa-2b consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.